Vijaya Diagnostic Centre Ltd. (IN:VIJAYA)
:VIJAYA
VIJAYA Stock Chart & Stats
₹1055.40
-₹0.50(-0.04%)
At close: 4:00 PM EST
₹1055.40
-₹0.50(-0.04%)
Day’s Range― - ―
52-Week Range₹847.90 - ₹1,179.55
Previous CloseN/A
Volume710.73K
Average Volume (3M)7.14K
Market Cap
₹100.16B
Enterprise Value₹103.53B
Total Cash (Recent Filing)₹2.58B
Total Debt (Recent Filing)₹3.65B
Price to Earnings (P/E)63.1
Beta0.49
Next Earnings
Jun 03, 2026EPS Estimate
4.37Next Dividend Ex-DateN/A
Dividend Yield0.2%
Share Statistics
EPS (TTM)4.20
Shares Outstanding102,724,940
10 Day Avg. Volume16,300
30 Day Avg. Volume7,139
Financial Highlights & Ratios
PEG Ratio3.49
Price to Book (P/B)12.57
Price to Sales (P/S)14.69
P/FCF Ratio77.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)21.49
Revenue Forecast (FY)₹9.42B
Bulls Say, Bears Say
Bulls Say
Revenue Growth & ProfitabilitySustained double‑digit revenue growth combined with very high gross and healthy net margins indicates durable demand, pricing power, and efficient cost structure. Over 2–6 months this supports reinvestment in network expansion, higher retention of profits, and resilience to volume swings.
Strong Cash GenerationHigh cash conversion and a 35% rise in free cash flow signal sustainable internal financing capacity for capex, new centres, and working capital. Robust OCF lowers reliance on external funding and provides flexibility for strategic investments over the medium term.
Healthy Balance Sheet & ROEModerate leverage, a strong equity base and near-18% ROE point to conservative capital structure and efficient use of capital. This financial strength supports endurance through downturns, funding organic growth, and selective M&A without excessive refinancing risk.
Bears Say
Fee-for-Service / Out-of-Pocket RelianceHeavy dependence on fee‑for‑service and out‑of‑pocket payments exposes revenue to affordability constraints, shifts in patient behavior, and reimbursement policy changes. Structural pressure on pricing or slower consumer demand could compress volumes and revenues over the medium term.
High Fixed Costs & Scale DependenceDiagnostics requires substantial fixed investment in labs and imaging; profitability depends on maintaining and growing volumes. If expansion stalls or utilization falls, operating leverage can quickly erode margins, making continued scale growth critical and execution‑sensitive.
Liabilities Could Be LoweredWhile leverage is moderate, the noted room to reduce liabilities suggests residual balance sheet obligations that could constrain strategic flexibility. If growth needs accelerate, incremental debt or liability servicing could pressure cash flow and limit optionality.
Vijaya Diagnostic Centre Ltd. News
VIJAYA FAQ
What was Vijaya Diagnostic Centre Ltd.’s price range in the past 12 months?
Vijaya Diagnostic Centre Ltd. lowest stock price was ₹847.90 and its highest was ₹1179.55 in the past 12 months.
What is Vijaya Diagnostic Centre Ltd.’s market cap?
Vijaya Diagnostic Centre Ltd.’s market cap is ₹100.16B.
When is Vijaya Diagnostic Centre Ltd.’s upcoming earnings report date?
Vijaya Diagnostic Centre Ltd.’s upcoming earnings report date is Jun 03, 2026 which is in 54 days.
How were Vijaya Diagnostic Centre Ltd.’s earnings last quarter?
Vijaya Diagnostic Centre Ltd. released its earnings results on Feb 13, 2026. The company reported ₹4.2 earnings per share for the quarter, beating the consensus estimate of ₹3.917 by ₹0.283.
Is Vijaya Diagnostic Centre Ltd. overvalued?
According to Wall Street analysts Vijaya Diagnostic Centre Ltd.’s price is currently Overvalued.
Does Vijaya Diagnostic Centre Ltd. pay dividends?
Vijaya Diagnostic Centre Ltd. pays a Annually dividend of ₹2 which represents an annual dividend yield of 0.2%. See more information on Vijaya Diagnostic Centre Ltd. dividends here
What is Vijaya Diagnostic Centre Ltd.’s EPS estimate?
Vijaya Diagnostic Centre Ltd.’s EPS estimate is 4.37.
How many shares outstanding does Vijaya Diagnostic Centre Ltd. have?
Vijaya Diagnostic Centre Ltd. has 102,724,940 shares outstanding.
What happened to Vijaya Diagnostic Centre Ltd.’s price movement after its last earnings report?
Vijaya Diagnostic Centre Ltd. reported an EPS of ₹4.2 in its last earnings report, beating expectations of ₹3.917. Following the earnings report the stock price went down -0.743%.
Which hedge fund is a major shareholder of Vijaya Diagnostic Centre Ltd.?
Currently, no hedge funds are holding shares in IN:VIJAYA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Vijaya Diagnostic Centre Ltd.
Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. It offers laboratory services, including clinical biochemistry, haematology and immune-haematology, clinical pathology, histopathology and cytopathology, microbiology, serology, cytogenetics, and molecular pathology; radiology and imaging services comprising magnetic resonance imaging, multi slice CT, CBCT (3D dental), mammography, DEXA/bone densitometry, ultrasound/color doppler, nuclear medicine and PET/CT, and digital X-ray; and cardiology, neurology, and gastroenterology services. The company also provides health checkups and home sample collection services. It has a network, which consists of 80 diagnostic center and 11 reference laboratories across 13 cities and towns in the states of Telangana and Andhra Pradesh, and in the National Capital Region and Kolkata. The company was founded in 1981 and is based in Hyderabad, India.
Technical Analysis
HealthCare Global Enterprises Ltd.
―
Krsnaa Diagnostics Limited
―
Metropolis Healthcare Ltd.
―
Unichem Laboratories Limited
―